December 2022 FDA Recall Drug by Remedyrepack Inc.
D-0077-2023 - Subpotent Drug

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on December 5, 2022 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed in Product was distributed to two different customers in MI. and the recall is currently terminated.

Recall Number: D-0077-2023

Reason for Recall
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Initiated
12-05-2022
Reported
12-14-2022
Quantity
9 boxes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to two different customers in MI.
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.

Batch or Lot Expiration Information

Lot# B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023